https://biotechmorning.com/news/pentagon-flu-vaccine-mandate-reversal-texas-outbreak Biotech Morning en 2026-07-20T14:30:29.198Z The Pentagon Dropped Its Flu Shot Rule. Weeks Later, 300 Troops Got Sick. https://biotechmorning.com/news/scribe-therapeutics-ipo-crispr-cholesterol Biotech Morning en 2026-07-20T14:29:39.782Z One Shot to Kill Your Cholesterol Forever? This Startup Is Betting $75 Million on It. https://biotechmorning.com/news/mwyngil-therapeutics-obesity-beyond-glp1 Biotech Morning en 2026-07-20T14:28:46.064Z This Obesity Startup Thinks GLP-1s Are Yesterday's News https://biotechmorning.com/news/bms-nvidia-vera-rubin-ai-supercomputer-drug-discovery Biotech Morning en 2026-07-20T14:27:52.036Z Big Pharma's New Drug Discovery Weapon Costs More Than Most Startups https://biotechmorning.com/news/china-insurance-glp1-pfizer-innovent Biotech Morning en 2026-07-20T14:26:57.092Z China's Insurance List Just Cracked Open for Two GLP-1 Newcomers https://biotechmorning.com/news/india-first-dengue-vaccine-qdenga-approved Biotech Morning en 2026-07-20T14:26:09.132Z India Just Got Its First Dengue Vaccine. It Only Took Forever. https://biotechmorning.com/news/ollin-biosciences-330m-ophthalmology-bet Biotech Morning en 2026-07-20T14:25:10.438Z The $330M Bet That Eyes Are the Next Big Thing in Biotech https://biotechmorning.com/news/senator-investigation-fda-rare-disease-rejections Biotech Morning en 2026-07-20T14:24:20.572Z The Senator Who Thinks the FDA Is Killing Rare Disease Patients https://biotechmorning.com/news/fda-liked-the-drug-hated-the-factory-lantheus Biotech Morning en 2026-07-20T14:23:30.464Z The FDA Liked the Drug. It Hated the Factory. https://biotechmorning.com/news/new-drug-launch-prices-dropped-2025 Biotech Morning en 2026-07-20T14:22:43.186Z New Drug Prices Just Dropped for the First Time in Years. Don't Celebrate Yet. https://biotechmorning.com/news/sonothera-ultrasound-gene-therapy-duchenne Biotech Morning en 2026-07-20T14:21:52.275Z The Gene Therapy That Sounds Too Good to Be True (Because It Uses Sound) https://biotechmorning.com/news/voquezna-nerd-approval-unlocks-millions Biotech Morning en 2026-07-19T14:21:58.238Z The Heartburn Drug That Just Unlocked 60 Million New Patients https://biotechmorning.com/news/parabilis-medicines-record-670-million-biotech-ipo Biotech Morning en 2026-07-19T14:21:02.502Z The $670 Million Bet on a Peptide Nobody Could Build https://biotechmorning.com/news/adc-replaces-chemo-first-line-lung-cancer Biotech Morning en 2026-07-19T14:20:16.203Z The Drug That Could Make Chemo Optional for Lung Cancer Patients https://biotechmorning.com/news/innocare-tyk2-vitiligo-new-challenger Biotech Morning en 2026-07-19T14:19:26.189Z The Skin Condition Nobody Could Treat Just Got a New Challenger https://biotechmorning.com/news/715-million-back-to-back-biotech-bets Biotech Morning en 2026-07-19T14:18:37.032Z $715 Million in 48 Hours: The Back-to-Back Bets Reshaping Biotech https://biotechmorning.com/news/supreme-court-roundup-bayer-preemption-ruling Biotech Morning en 2026-07-19T14:17:48.954Z The Ruling That Just Killed 60,000 Lawsuits https://biotechmorning.com/news/hengrui-elevar-fda-third-manufacturing-rejection Biotech Morning en 2026-07-19T14:16:59.642Z The Drug That Works But Can't Get Made